Latest News

States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.

CROI 2026 showcased breakthroughs alongside funding crisis disrupting global and domestic HIV services.

Barriers to PrEP access for minors in Southern states: legal and political obstacles.

Major HIV research breakthroughs from CROI 2024: long-acting treatments and prevention advances.

Payer denial of PrEP disproportionately fails Black women and marginalized communities.

Q2 2023 Watch: Braidwood decision impacts PrEP coverage; ADAP coverage analysis and Medicaid program updates.

Australian study: 1% viral load suppression increase correlates with 6% decrease in HIV diagnoses.

The 'PrEP Penalty' describes insurance and policy discrimination against PrEP users.

Biden FY2024 budget includes $9.7B PrEP program and $11B Hepatitis Elimination Program.

Tennessee rejects $8.3M in federal HIV prevention funding, threatening surveillance and care programs.

S.4395 would divert Ryan White resources from PLWHA to PrEP, threatening the safety net for vulnerable populations.

ADAP Advocacy Association Fireside Chats resume with discussions on utilization management and EHE progress.

PrEP access remains limited by payer practices like prior authorizations despite ACA coverage requirements.

Medication abandonment disproportionately affects Black patients; PrEP users 41% more likely to abandon.

Access Health Louisiana uses animated series and radio to educate communities on HIV, HCV, and public health.

CDC updates STI treatment guidelines; ACIP recommends universal adult HBV vaccination and HPV catch-up.

Analyzes Biden health policy priorities including drug pricing reform and Medicare expansion.

CANN roundtable discusses pandemic's impacts on HIV, HCV, STI, and SUD programs and funding weaknesses.

Merck-Gilead partnership on long-acting injectables Islatravir and Lenacapavir for HIV treatment.